Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura

Pediatric Nephrology

Volumn 26, Issue 11, 2011, Pages 1989-1993

  Keskin, Nurcan ^a   Civilibal, Mahmut ^b   Elevli, Murat ^a   Koldas, MacIt ^a   Duru, Nilgun Selcuk ^a   Ozturk, Humeyra ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Ataköy 7 8ksm Mimar Sinan Sitesi ^*  (Turkey)

Author keywords

Advanced oxidation protein product; Children; Henoch Schonlein purpura; Oxidative stress; Protein oxidation

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; C REACTIVE PROTEIN; IMMUNOGLOBULIN A;

ADOLESCENT; ANAPHYLACTOID PURPURA; ARTHRALGIA; ARTHRITIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL DISEASE; HEMATURIA; HUMAN; KIDNEY DISEASE; LEUKOCYTE COUNT; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; REMISSION; SCHOOL CHILD; THROMBOCYTE COUNT;

ADOLESCENT; BLOOD PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PURPURA, SCHOENLEIN-HENOCH; SERUM ALBUMIN;

EID: 83155180659     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1905-y     Document Type: Article

References (19)

1. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. II. Final classification criteria. Ann RheumDis 69:798-806
2. Skvarilová M, Bulava A, Stejskal D, Adamovská S, Bartek J (2005) Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149:83-87
3. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C (2003) Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272-1280 (Pubitemid 36826946)
4. Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82:291-295 (Pubitemid 27182306)
5. Witko-Sarsat V, FriedlanderM, Capeillére-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49(5):1304-1313 (Pubitemid 26166404)
6. Buyan N, Erbas D, Akkok N, Oz E, Biberoǧlu G, Hasanoǧlu E (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch-Schonlein Purpura. Prostaglandins Leukot Essent Fatty Acids 59:181-184 (Pubitemid 28505109)
7. Shah SV (1988) Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 254:337-344
8. Rahman MA, Emancipator SS, Sedor JR (1988) Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis. J Lab Clin Med 112:619-626 (Pubitemid 19006795)
9. Demircin G, öner A, ünver Y, Bülbül M, Erdoǧan O (1998) Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch-Schönlein purpura. Acta Paediatr 87:848-852 (Pubitemid 28409061)
10. Pryor WA (1986) Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu Rev Physiol 48:657-667 (Pubitemid 16047640)
11. Erdoǧan O, öner A, Ayd?n A, Işimer A, Demircin G, Bülbül M (2003) Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura. Acta Paediatr 92:546-550 (Pubitemid 37088698)
12. Ece A, Kelekçi S, Kocamaz H, Hekimoǧlu A, Balik H, Yolbaş I, Erel O (2008) Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch- Schönlein purpura. Clin Rheumatol 27:163-169
13. Chen T, Guo ZP, Zhang YH, Gao Y (2009) Elevated serumxanthine oxidase activities in patients with Henoch-Schönlein purpura. Clin Rheumatol 28:1355-1356
14. Yilmaz A, Emre S, Agachan B, Bilge I, Yilmaz H, Ergen A, Isbir T, Sirin A (2009) Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura. J Nephrol 22:726-732
15. Lin SJ, Huang JL, Hsieh KH (1998) Clinical and laboratory correlation of acute Henoch-Schönlein purpura in children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 39:94-98
16. Maugeri N, Baldini M, Rovere-Querini P, Maseri A, Sabbadini MG, Manfredi AA (2009) Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks? Autoimmunity 42:386-388
17. Straface E, Gambardella L, Metere A, Marchesi A, Palumbo G, Cortis E, Villani A, Pietraforte D, Viora M, Malorni W, Del Principe D (2010) Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease. Biochem Biophys Res Commun 392:426-430
18. Tian X, He XL, Fang YB, Zou RY (2009) Roles of platelet and its regulating factors in immune vasculitis in young rabbits. Zhongguo Dang Dai Er Ke Za Zhi 11:850-853
19. Dolezalová P, Telekesová P, Nemcová D, Hoza J (2002) Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations. Clin Exp Rheumatol 20:249-254 (Pubitemid 34413709)